Visualitzant per autor/a "Navas, María J."
Ara mostrant els elements 1-2 de 2
-
Cross-protection against African swine fever virus upon intranasal vaccination is associated with an adaptive-innate immune crosstalk
Bosch Camós, Laia; Alonso, Uxía; Esteve-Codina, Anna; Chang, Chia-Yu; Martín-Mur, Beatriz; Accensi, Francesc; Muñoz, Marta; Navas, María J.; Dabad, Marc; Vidal, Enric; Pina-Pedrero, Sonia; Pleguezuelos, Patricia; Caratù, Ginevra; Salas, María L.; Liu, Lihong; Bataklieva, Stanimira; Gavrilov, Boris; Rodriguez, Fernando; Argilaguet, Jordi (PLoS Pathogens, 2022-11-09) Sanitat AnimalAfrican swine fever virus (ASFV) is causing a worldwide pandemic affecting the porcine industry and leading to important global economic consequences. The virus causes a highly lethal hemorrhagic disease ... -
M448R and MGF505-7R: Two African Swine Fever Virus Antigens Commonly Recognized by ASFV-Specific T-Cells and with Protective Potential
Bosch-Camós, Laia; López, Elisabet; Collado, Javier; Navas, María J.; Blanco-Fuertes, Miguel; Pina-Pedrero, Sonia; Accensi, Francesc; Salas, Maria Luisa; Mundt, Egbert; Nikolin, Veljko; Rodríguez, Fernando (Vaccines, 2021-05-14) Sanitat AnimalAfrican swine fever (ASF) is today′s number one threat for the global swine industry. Neither commercial vaccine nor treatment is available against ASF and, thus far, only live attenuated viruses (LAV) ...